|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03309 C-MER MEDICAL
Nominal 
1.980 0.000 (0.000%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 1,923,964 | 11.090% | 1,731,903 | 1,112,577 | 699,545 | 576,209 |
| Cost of Sales | (1,305,002) | 1.619% | (1,284,206) | (754,349) | (505,468) | (384,888) |
| Gross Profit | 618,962 | 38.255% | 447,697 | 358,228 | 194,077 | 191,321 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 3,164 | -91.629% | 37,799 | 10,652 | (276) | (196) | |
| Profit / (Loss) before Taxation | 124,269 | -- | (11,227) | 26,875 | 2,504 | 53,208 | |
| Taxation | (37,934) | 8.389% | (34,998) | (10,645) | (10,916) | (14,086) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (24,337) | -- | 24,350 | 5,631 | 2,166 | 2,313 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 61,998 | -- | (21,875) | 21,861 | (6,246) | 41,435 | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | (1,768) | -- | 12,544 | 8,520 | 5,296 | (5,950) |
| Depreciation & Amortisation | 220,990 | -1.359% | 224,034 | 148,581 | 113,562 | 78,538 |
| Directors' Emoluments | 11,966 | -6.347% | 12,777 | 14,079 | 9,118 | 5,957 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 4.940 | -- | -1.770 | 1.900 | -0.570 | 3.960 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 2.000 | 2.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | 50.505% |
| Cash flow per share ($) | 0.288 | -- | 0.134 | 0.126 | 0.099 | 0.131 |
| NBV per share ($) | 1.470 | -- | 1.473 | 1.157 | 1.128 | 0.815 |
| Remarks: | Real time quote last updated: 25/11/2024 08:20 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 30,763,000 |
| %Change | 3.377% |
| EPS / (LPS) | HKD 0.025 |
| NBV Per Share ($) | HKD 1.464 |